Furthermore, the adequacy of the incretin effect for capturing the capacity for glucose metabolism varies (12, 22); for example, the numerical incretin effect evaluated by insulin secretion does not differ before and after DPP-4 inhibitor treatment in patients with T2D (23, 24). Here, GCG is linked to type 2 diabetes mellitus.